These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29799952)

  • 1. Whole-Body Distribution and Clinical Association of Telangiectases in Systemic Sclerosis.
    Jouvray M; Launay D; Dubucquoi S; Sobanski V; Podevin C; Lambert M; Morell-Dubois S; Maillard H; Hatron PY; Hachulla E; Giovannelli J
    JAMA Dermatol; 2018 Jul; 154(7):796-805. PubMed ID: 29799952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory characteristics of systemic sclerosis patients with pulmonary arterial hypertension in China.
    Huang J; Li M; Tian Z; Hsieh E; Wang Q; Liu Y; Xu D; Hou Y; Zhao J; Guo X; Lai J; Hu C; Song N; Sun Q; Sun Q; Zhang F; Zhao Y; Zeng X
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-115-21. PubMed ID: 25372797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulnar Artery Occlusion and Severity Markers of Vasculopathy in Systemic Sclerosis: A Multicenter Cross-Sectional Study.
    Lescoat A; Yelnik CM; Coiffier G; Wargny M; Lamotte C; Cazalets C; Belhomme N; Ballerie A; Hatron PY; Launay D; Perdriger A; Sobanski V; Hachulla E; Jégo P
    Arthritis Rheumatol; 2019 Jun; 71(6):983-990. PubMed ID: 30552835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with the 6-minute walk distance in patients with systemic sclerosis.
    Sanges S; Giovannelli J; Sobanski V; Morell-Dubois S; Maillard H; Lambert M; Podevin C; Lamblin N; De Groote P; Bervar JF; Perez T; Matran R; Rémy-Jardin M; Hatron PY; Hachulla É; Launay D
    Arthritis Res Ther; 2017 Dec; 19(1):279. PubMed ID: 29246248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension.
    Shah AA; Wigley FM; Hummers LK
    J Rheumatol; 2010 Jan; 37(1):98-104. PubMed ID: 19955048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nailfold capillaroscopic parameters and skin telangiectasia patterns in patients with systemic sclerosis.
    Pizzorni C; Giampetruzzi AR; Mondino C; Facchiano A; Abeni D; Paolino S; Ruaro B; Smith V; Sulli A; Cutolo M
    Microvasc Res; 2017 May; 111():20-24. PubMed ID: 27989404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
    van den Hoogen F; Khanna D; Fransen J; Johnson SR; Baron M; Tyndall A; Matucci-Cerinic M; Naden RP; Medsger TA; Carreira PE; Riemekasten G; Clements PJ; Denton CP; Distler O; Allanore Y; Furst DE; Gabrielli A; Mayes MD; van Laar JM; Seibold JR; Czirjak L; Steen VD; Inanc M; Kowal-Bielecka O; Müller-Ladner U; Valentini G; Veale DJ; Vonk MC; Walker UA; Chung L; Collier DH; Ellen Csuka M; Fessler BJ; Guiducci S; Herrick A; Hsu VM; Jimenez S; Kahaleh B; Merkel PA; Sierakowski S; Silver RM; Simms RW; Varga J; Pope JE
    Ann Rheum Dis; 2013 Nov; 72(11):1747-55. PubMed ID: 24092682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital ulcers predict a worse disease course in patients with systemic sclerosis.
    Mihai C; Landewé R; van der Heijde D; Walker UA; Constantin PI; Gherghe AM; Ionescu R; Rednic S; Allanore Y; Avouac J; Czirják L; Hachulla E; Riemekasten G; Cozzi F; Airò P; Cutolo M; Mueller-Ladner U; Matucci-Cerinic M;
    Ann Rheum Dis; 2016 Apr; 75(4):681-6. PubMed ID: 25688073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria for systemic sclerosis in patients from a capillaroscopy clinic.
    Melchor S; Joven BE; Andreu JL; Loza E; Garcia de Yebenes MJ; Carmona L; Carreira PE
    Semin Arthritis Rheum; 2016 Dec; 46(3):350-355. PubMed ID: 27373498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin Telangiectasia and the Identification of a Subset of Systemic Sclerosis Patients With Severe Vascular Disease.
    Hurabielle C; Avouac J; Lepri G; de Risi T; Kahan A; Allanore Y
    Arthritis Care Res (Hoboken); 2016 Jul; 68(7):1021-7. PubMed ID: 26474084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China.
    Zhang SZ; Xu D; Li MT; Hou Y; Wang Q; Tian Z; Liu YT; Guo XX; Lai JZ; Zhao JL; Hu CJ; Song N; Sun QN; Zhang FC; Zhao Y; Zeng XF
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S106-10. PubMed ID: 26005882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of telangiectasia in scleroderma.
    Mould TL; Roberts-Thomson PJ
    Asian Pac J Allergy Immunol; 2000 Dec; 18(4):195-200. PubMed ID: 11316039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial vasculopathy in systemic sclerosis: computerized tomography (CT) angiographic features of macrovascular and microvascular upper limbs arteries.
    Emad Y; Al-Sherbeni H; Ragab Y; Abo-El-Youn I; El-Shaarawy N; Nassar DY; Fathy A; Al-Hanafi H; Rasker JJ
    Joint Bone Spine; 2014 Oct; 81(5):433-7. PubMed ID: 24956984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
    Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
    Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension.
    Bernstein EJ; Gordon JK; Spiera RF; Huang WT; Horn EM; Mandl LA
    Rheumatology (Oxford); 2017 Jan; 56(1):87-94. PubMed ID: 28028158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Utility of Plasma Vascular Biomarkers in Systemic Sclerosis: A Prospective Longitudinal Analysis.
    Mecoli CA; Shah AA; Boin F; Wigley FM; Hummers LK
    Arthritis Rheumatol; 2020 Aug; 72(8):1341-1349. PubMed ID: 32200572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-Minute Walk Test as a Predictor of Diagnosis, Disease Severity, and Clinical Outcomes in Scleroderma-Associated Pulmonary Hypertension: The DIBOSA Study.
    Gadre A; Ghattas C; Han X; Wang X; Minai O; Highland KB
    Lung; 2017 Oct; 195(5):529-536. PubMed ID: 28646245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial hypertension treated with angiotensin converting enzyme inhibitors and glucocorticoids are independent risk factors associated with decreased glomerular filtration rate in systemic sclerosis.
    Ostojic P; Stojanovski N
    Rheumatol Int; 2017 Mar; 37(3):363-368. PubMed ID: 28008457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and laboratory features of Japanese patients with scleroderma and telangiectasia.
    Ashida R; Ihn H; Mimura Y; Jinnin M; Asano Y; Kubo M; Tamaki K
    Clin Exp Dermatol; 2009 Oct; 34(7):781-3. PubMed ID: 19508567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis.
    Lefèvre G; Dauchet L; Hachulla E; Montani D; Sobanski V; Lambert M; Hatron PY; Humbert M; Launay D
    Arthritis Rheum; 2013 Sep; 65(9):2412-23. PubMed ID: 23740572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.